170 related articles for article (PubMed ID: 10212345)
1. White-coat hypertension: not guilty when correctly defined.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Porcellati C
Blood Press Monit; 1998 Jun; 3(3):147-152. PubMed ID: 10212345
[TBL] [Abstract][Full Text] [Related]
2. White-coat hypertension in adults and children.
Verdecchia P
Blood Press Monit; 1999; 4(3-4):175-9. PubMed ID: 10490871
[TBL] [Abstract][Full Text] [Related]
3. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Sacchi N; Guerrieri M; Comparato E; Porcellati C
Blood Press Monit; 1996 Jun; 1(3):217-222. PubMed ID: 10226230
[TBL] [Abstract][Full Text] [Related]
4. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
5. [White-coat hypertension].
Verdecchia P; Porcellati C
G Ital Cardiol; 1995 Jul; 25(7):899-909. PubMed ID: 7557039
[TBL] [Abstract][Full Text] [Related]
6. Long-term changes in clinic blood pressure in patients with white-coat hypertension.
Saito I; Murata K; Tsujioka M; Kawabe H; Saruta T
Blood Press Monit; 1998 Apr; 3(2):97-100. PubMed ID: 10212337
[TBL] [Abstract][Full Text] [Related]
7. ["White-coat hypertension": variation of normality or of hypertension?].
Carmona J; Amado P; Vasconcelos N; Santos I; Pinto C; Forte G; Arsénio A; Nazaré J
Rev Port Cardiol; 1998 Jun; 17(6):505-12. PubMed ID: 9677828
[TBL] [Abstract][Full Text] [Related]
8. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
[TBL] [Abstract][Full Text] [Related]
9. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
[TBL] [Abstract][Full Text] [Related]
10. White coat hypertension and white coat effect. Similarities and differences.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Zampi I; Gattobigio R; Sacchi N; Porcellati C
Am J Hypertens; 1995 Aug; 8(8):790-8. PubMed ID: 7576395
[TBL] [Abstract][Full Text] [Related]
11. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years).
Polónia JJ; Santos AR; Gama GM; Basto F; Bettencourt PM; Martins LR
Blood Press Monit; 1997 Dec; 2(6):289-295. PubMed ID: 10388905
[TBL] [Abstract][Full Text] [Related]
12. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
[TBL] [Abstract][Full Text] [Related]
13. White coat effect, blood pressure and mortality in men: prospective cohort study.
Strandberg TE; Salomaa V
Eur Heart J; 2000 Oct; 21(20):1714-8. PubMed ID: 11032699
[TBL] [Abstract][Full Text] [Related]
14. Office hypertension: abnormal blood pressure regulation and increased sympathetic activity compared with normotension.
Middeke M; Lemmer B
Blood Press Monit; 1996 Oct; 1(5):403-407. PubMed ID: 10226267
[TBL] [Abstract][Full Text] [Related]
15. Repeated office blood pressure controls reduce the prevalence of white-coat hypertension and detect a group of white-coat normotensive patients.
Fogari R; Corradi L; Zoppi A; Lusardi P; Poletti L
Blood Press Monit; 1996 Feb; 1(1):51-54. PubMed ID: 10226202
[TBL] [Abstract][Full Text] [Related]
16. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.
Gustavsen PH; Høegholm A; Bang LE; Kristensen KS
J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of white-coat response in patients with treated hypertension.
MacDonald MB; Laing GP; Wilson MP; Wilson TW
CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
[TBL] [Abstract][Full Text] [Related]
18. Defining normal ambulatory blood pressure in relation to target organ damage and prognosis.
Verdecchia P; Porcellati C
Am J Hypertens; 1993 Jun; 6(6 Pt 2):207S-210S. PubMed ID: 8347320
[TBL] [Abstract][Full Text] [Related]
19. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring.
Ben-Dov IZ; Ben-Arie L; Mekler J; Bursztyn M
Int J Cardiol; 2007 May; 117(3):355-9. PubMed ID: 16879886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
